About: Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $7.52 (-3.03%)
EOLS NASDAQ Evolus Inc
Evolus Inc share price
EOLS price activity
Last Price
$7.520
Change (24hr)
-0.24 USD (-3.03%)
Volume
386.89K
Volume (4w avg)
-
Open
$7.68
Day Range
$7.52 - $7.68
Previous Close
$7.75
Last Trade
13 Oct, 7:08 pm GMT+0
Delayed
13 Oct, 7:08 pm GMT+0
EOLS price performance
Delayed
13 Oct, 7:08 pm GMT+0
EOLS Market Signals